Table 1
Sociodemographic and clinical characteristics of deceased adults in the regions of the initiatives (n = 37,468).
| DECEASED ADULTS IN THE REGIONS OF SELECTED INITIATIVES PRE-IMPLEMENTATION n = 17,920 % (n) | DECEASED ADULTS IN THE REGIONS OF SELECTED INITIATIVES POST-IMPLEMENTATION n = 19,548 % (n) | RECEIVED INTEGRATED PALLIATIVE CARE n = 210 % (n) | MATCHED CONTROL GROUP n = 420 % (n) | |
|---|---|---|---|---|
| Age (years) | ||||
| 18–69 | 20.9% (3,750) | 20.4% (3,995) | 35.2% (74) | 35.2% (148) |
| 70–79 | 21.5% (3,856) | 22.7% (4,445) | 32.4% (68) | 32.4% (136) |
| 80–89 | 35.6% (6,378) | 36.6% (7,144) | 25.7% (54) | 25.7% (108) |
| 90+ | 22.0% (3,936) | 20.2% (3,964) | 6.7% (14) | 6.7% (28) |
| Sex | ||||
| Female | 52.0% (9,319) | 51.3% (10,018) | 50.5% (106) | 50.5% (212) |
| Cancer | ||||
| Yes | 29.6% (5,295) | 29.0% (5,662) | 69.1% (145) | 69.1% (290) |
| No | 70.5% (12,625) | 71.0% (13,886) | 31.0% (65) | 31.0% (130) |

Figure 1
Potentially inappropriate end-of-life care of deceased adults pre-implementation (n = 17,920) compared to post-implementation (n = 19,548).
All items are measured 30 days before death, except for in-hospital death.
† Total score if one of the six items was obtained.
‡ Only for deceased adults with cancer.
* Statistically significant difference (p < 0.05).
Eol, end of life; ICU, intensive care unit.

Figure 2
Potentially inappropriate end-of-life care of deceased adults who received integrated palliative care (n = 210) compared to a matched control group (n = 420).
All items are measured 30 days before death, except for in-hospital death.
† Total score if one of the six items was obtained.
‡ Only for deceased adults with cancer.
* Statistically significant difference (p < 0,05).
Eol, end of life; ICU, intensive care unit.

Figure 3
Mean healthcare costs in the last 30 days of deceased adults who received integrated palliative care (n = 210) compared to the matched control group who did not receive integrated palliative care (n = 420).
* Statistically significant difference (p < 0,05).
